These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Resistance of Streptococcus pneumoniae to fluoroquinolones--United States, 1995-1999. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2001 Sep 21; 50(37):800-4. PubMed ID: 11785571 [Abstract] [Full Text] [Related]
4. Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin. Fogarty C, Goldschmidt R, Bush K. Clin Infect Dis; 2000 Aug 21; 31(2):613-5. PubMed ID: 10987733 [Abstract] [Full Text] [Related]
5. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia. Davidson R, Cavalcanti R, Brunton JL, Bast DJ, de Azavedo JC, Kibsey P, Fleming C, Low DE. N Engl J Med; 2002 Mar 07; 346(10):747-50. PubMed ID: 11882730 [No Abstract] [Full Text] [Related]
11. Cefotaxime acts synergistically with levofloxacin in experimental meningitis due to penicillin-resistant pneumococci and prevents selection of levofloxacin-resistant mutants in vitro. Kühn F, Cottagnoud M, Acosta F, Flatz L, Entenza J, Cottagnoud P. Antimicrob Agents Chemother; 2003 Aug 15; 47(8):2487-91. PubMed ID: 12878509 [Abstract] [Full Text] [Related]
12. Preincubation of pneumococci with beta-lactams alone or combined with levofloxacin prevents quinolone-induced resistance without increasing intracellular levels of levofloxacin. Cottagnoud P, Johnson M, Cottagnoud M, Piddock L. Antimicrob Agents Chemother; 2005 Aug 15; 49(8):3517-9. PubMed ID: 16048972 [Abstract] [Full Text] [Related]
13. A new twist on an old problem: a case of pediatric meningitis caused by multidrug-resistant Streptococcus pneumoniae serotype 19A. Ciccotelli W, Poutanen S, Morris S, Alqahtani M, Cox P, Low D, Pillai D, Opavsky M. Can Commun Dis Rep; 2008 Nov 15; 34(11):1-6. PubMed ID: 19051388 [Abstract] [Full Text] [Related]
15. Emergence of levofloxacin-resistant pneumococci in immunocompromised adults after therapy for community-acquired pneumonia. Anderson KB, Tan JS, File TM, DiPersio JR, Willey BM, Low DE. Clin Infect Dis; 2003 Aug 01; 37(3):376-81. PubMed ID: 12884162 [Abstract] [Full Text] [Related]
16. Pharmacodynamics of levofloxacin and ofloxacin against Streptococcus pneumoniae. Bauernfeind A. J Antimicrob Chemother; 1999 Jun 01; 43 Suppl C():77-82. PubMed ID: 10404343 [Abstract] [Full Text] [Related]
18. Call for the international adoption of microbiological breakpoints for fluoroquinolones and Streptococcus pneumoniae. Schurek KN, Adam HJ, Hoban DJ, Zhanel GG. Int J Antimicrob Agents; 2006 Sep 01; 28(3):266-9. PubMed ID: 16904294 [Abstract] [Full Text] [Related]
19. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia. Tillotson GS, Zhao X, Drlica K. N Engl J Med; 2002 Jul 04; 347(1):65-7; author reply 65-7. PubMed ID: 12102062 [No Abstract] [Full Text] [Related]
20. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia. Zhanel GG, Hoban DJ, Chan CK. N Engl J Med; 2002 Jul 04; 347(1):65-7; author reply 65-7. PubMed ID: 12102063 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]